128 related articles for article (PubMed ID: 3779515)
1. Effects of acute and chronic administration of sotalol on the blood pressure and the sympathoadrenal activity of anesthetized deoxycorticosterone acetate-salt hypertensive rats.
Bouvier M; de Champlain J
Can J Physiol Pharmacol; 1986 Sep; 64(9):1164-9. PubMed ID: 3779515
[TBL] [Abstract][Full Text] [Related]
2. Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats.
de Champlain J; Bouvier M; Drolet G
Can J Physiol Pharmacol; 1987 Aug; 65(8):1605-14. PubMed ID: 2825939
[TBL] [Abstract][Full Text] [Related]
3. Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension.
Drolet G; de Champlain J
Clin Invest Med; 1992 Aug; 15(4):360-70. PubMed ID: 1516293
[TBL] [Abstract][Full Text] [Related]
4. Increased sympatho-adrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats.
Bouvier M; de Champlain J
J Hypertens; 1986 Apr; 4(2):157-63. PubMed ID: 3011889
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats.
Drolet G; Bouvier M; de Champlain J
J Hypertens; 1989 Mar; 7(3):237-42. PubMed ID: 2708820
[TBL] [Abstract][Full Text] [Related]
6. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
Lange DL; Haywood JR; Hinojosa-Laborde C
Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell catecholamine levels in normotensive and DOCA-salt hypertensive rats.
Bouvier M; Farley L; de Champlain J
Am J Physiol; 1987 Aug; 253(2 Pt 2):H270-5. PubMed ID: 3618801
[TBL] [Abstract][Full Text] [Related]
8. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
Moreau P; Drolet G; Yamaguchi N; de Champlain J
Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
[TBL] [Abstract][Full Text] [Related]
9. Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats.
Bouvier M; de Champlain J
J Auton Nerv Syst; 1986 Feb; 15(2):191-5. PubMed ID: 3958436
[TBL] [Abstract][Full Text] [Related]
10. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
11. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
Moreau P; Drolet G; Yamaguchi N; de Champlain J
Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
[TBL] [Abstract][Full Text] [Related]
12. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
Reid JL; Zivin JA; Kopin IJ
Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
[TBL] [Abstract][Full Text] [Related]
13. Enhanced depressor effect of muscimol in the DOCA/NaCl hypertensive rat: evidence for altered GABAergic activity in brain.
Nagahama S; Dawson R; Oparil S
Proc Soc Exp Biol Med; 1985 Nov; 180(2):277-83. PubMed ID: 4048165
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
Tsuda K; Masuyama Y
Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
Sato Y; Ogata E; Fujita T
Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
[TBL] [Abstract][Full Text] [Related]
16. Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.
Kandlikar SS; Fink GD
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1781-7. PubMed ID: 21357502
[TBL] [Abstract][Full Text] [Related]
17. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
Nagahama S; Chen YF; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
[TBL] [Abstract][Full Text] [Related]
18. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
Chen YF; Nagahama S; Winternitz SR; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
20. Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats.
Bouvier M; de Champlain J
Clin Exp Hypertens A; 1985; 7(11):1629-45. PubMed ID: 4085138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
